Eight Treatments For TRD: Systematic Review From China
Out on PubMed, from authors in China, is this paper: Efficacy and safety of eight enhanced therapies for treatment-resistant depression: A systematic review and network meta-analysis of RCTs. Guo Q, Guo L, Wang Y, Shang S. Psychiatry Res. 2024 Jun 20;339:116018. doi: 10.1016/j.psychres.2024.116018. Online ahead of print. PMID: 38924903 The abstract is copied below: Background: Treatment-Resistant Depression (TRD) challenges psychiatric treatment, with existing guidelines covering only a subset of augmentation strategies. Methods: A network meta-analysis following PRISMA guidelines examined the efficacy and safety of TRD treatments, analyzing 72 randomized controlled trials from eight databases, assessing response and remission rates, tolerability, and safety through the Cochrane Risk of Bias Tool and CINeMA framework. Findings: Including 12,105 participants, the analysis highlighted ECT, Ketamine, Esketamine, and Psilocybin as superior first-line treatments due to their opti...